thinkpool

기술도입ㆍ이전 계약체결 및 계약 중도해지 
+---------------------------------------+--------------------------------------------------+ 
| 1. 구분                               |                   기술이전계약                   | 
+---------------------------------------+--------------------------------------------------+ 
| 2. 계약상대방                         |                 (주)바이오라딕스                 | 
+---------------------------------------+--------------------------------------------------+ 
|    - 회사와의 관계                    |                        -                         | 
+-----------+---------------------------+--------------------------------------------------+ 
| 3. 기술의 | 도입ㆍ이전 대상           | 관절염 및 골관절대사 질환 치료 천연물 신약 개발  | 
|           +---------------------------+--------------------------------------------------+ 
| 주요내용  | 도입ㆍ이전 방법           |        국내외 전용 실시권 및 사업권 확보         | 
+-----------+---------------------------+--------------------------------------------------+ 
| 4. 계약의 | 계약조건                  |                총계약금액:  3억8천만원           | 
| 주요내용  |                           |                경상실시료: 총매출액의 5%         | 
|           +-----------+---------------+--------------------------------------------------+ 
|           | 계약기간  |     시작일    |                 2006년 11월 07일                 | 
|           |           +---------------+--------------------------------------------------+ 
|           |           |     종료일    |                        -                         | 
+---------------------------------------+--------------------------------------------------+ 
| 5. 계약체결일(중도해지일)자           |                 2006년 11월 07일                 | 
+---------------------------------------+--------------------------------------------------+ 
| 6. 이사회 결의일(결정일)              |                        -                         | 
+-----------+---------------------------+--------------------------------------------------+ 
|    - 사외 |          참석(명)         |                        -                         | 
|           +---------------------------+--------------------------------------------------+ 
| 이사 참석 |          불참(명)         |                        -                         | 
| 여부      |                           |                                                  | 
+---------------------------------------+--------------------------------------------------+ 
|    - 감사(사외이사가 아닌 감사위원)   |                        -                         | 
|       참석여부                        |                                                  | 
+---------------------------------------+--------------------------------------------------+ 
| 7. 공정거래위원회 신고대상 여부       |                      아니오                      | 
+---------------------------------------+--------------------------------------------------+ 
| 8. 기타 투자판단에 참고할 사항        | 1.BDX-1은 한의학계의 관절염 치료 처방을 원개발   | 
|                                       |  사인 바이오라딕스가 개량발전시킨 기술로 2004년  | 
|                                       |  국내특허를 취득하였으며 2002년 국제특허 예비심  | 
|                                       |  사를 통과.                                      | 
|                                       | 2.회사는 전임상 및 임상시험을 통하여 관절염 치료 | 
|                                       |    제로서 2009년 초에 BDX-1을 상품화할 계획.     | 
|                                       | 3.계약일로부터 기술 및 개량기술의 특허가 만료되  | 
|                                       |     는 시점 또는 제품출시 후 10년 중 오래 지속되 | 
|                                       | 는    것을 기준.                                 | 
|                                       +-----------------------+--------------------------+ 
|                                       |      ※ 관련공시      |            -             | 
+------------------------------------------------------------------------------------------+